IRTC logo

iRhythm Holdings Inc. (IRTC)

$89.67

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on IRTC

Market cap

$3.01B

EPS

-1.16

P/E ratio

--

Price to sales

4.26

Dividend yield

--

Beta

1.39459

Price on IRTC

Previous close

$90.83

Today's open

$90.52

Day's range

$89.35 - $92.04

52 week range

$82.85 - $192.47

Profile about IRTC

CEO

Quentin S. Blackford

Employees

2400

Headquarters

San Francisco, CA

Exchange

Nasdaq Global Select

Shares outstanding

33618146

Issue type

Common Stock

IRTC industries and sectors

Healthcare

Medical Equipment & Supplies

News on IRTC

iRhythm Announces $100 Million Accelerated Share Repurchase Agreement

SAN FRANCISCO, Nov. 17, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank, National Association (JPMorgan) for $100 million of its common stock, as part of its previously announced $200 million share repurchase authorization.

news source

GlobeNewsWire • 14 hours ago

news preview

IRHYTHM HOLDINGS, INC. INVESTIGATION: IRTC Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

NEW YORK--(BUSINESS WIRE)---- $IRTC #ClassActionLawsuit--The law firm of Kirby McInerney LLP is investigating potential claims against iRhythm Holdings, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired iRhythm securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com.

news source

Business Wire • Nov 13, 2026

news preview

iRhythm Announces Approval of $200 Million Share Repurchase Program

SAN FRANCISCO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that on November 10, 2026, its Board of Directors approved a share repurchase program with authorization to purchase up to $200 million of the company's outstanding common stock.

news source

GlobeNewsWire • Nov 11, 2026

news preview

What iRhythm Technologies (IRTC) Said on Its Q3 Earnings Call

iRhythm Technologies NASDAQ: IRTC raised its 2026 revenue and profitability outlook after reporting third-quarter growth driven by its core Zio monitor business, even as demand for its Zio AT telemetry product fell short of expectations.

news source

MarketBeat • Nov 6, 2026

news preview

IRTC Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into iRhythm Technologies, Inc. (IRTC)

A revenue shortfall against Wall Street consensus, flat Zio AT sales, and the Zio MCT FDA submission has now slipped into 2027. SueWallSt notifies investors of a pending investigation into potential securities law violations on behalf of investors who lost money.

news source

PRNewsWire • Nov 6, 2026

news preview

iRhythm Holdings to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the following investor conferences.

news source

GlobeNewsWire • Nov 6, 2026

news preview

iRhythm Holdings, Inc. (IRTC) Q3 2026 Earnings Call Transcript

iRhythm Holdings, Inc. (IRTC) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 6, 2026

news preview

iRhythm Holdings Announces Third Quarter 2026 Financial Results

SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended September 30, 2026.

news source

GlobeNewsWire • Nov 5, 2026

news preview

iRhythm Holdings, Inc. (IRTC) Q3 Earnings Surpass Estimates

iRhythm Holdings, Inc. (IRTC) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.06 per share a year ago.

news source

Zacks Investment Research • Nov 6, 2026

news preview

iRhythm Holdings, Inc. (IRTC) Earnings Expected to Grow: Should You Buy?

IRHYTHM HLDGS (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

news source

Zacks Investment Research • Oct 29, 2026

news preview

¹ Disclosures

Get started with M1

Invest in iRhythm Holdings Inc.

Open an M1 investment account to buy and sell iRhythm Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in IRTC on M1